HOUSE OF REPRESENTATIVES |
H.B. NO. |
250 |
THIRTY-THIRD LEGISLATURE, 2025 |
|
|
STATE OF HAWAII |
|
|
|
|
|
|
||
|
A BILL FOR AN ACT
relating to health.
BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF HAWAII:
SECTION 1. The legislature finds that prior authorization is a health plan cost control process that requires physicians, health care professionals, and hospitals to obtain advance approval from a health plan before a specific service to a patient to qualify for payment or coverage. Each plan has its own policies and procedures that health care providers are required to navigate to have services they prescribe for their patients approved for payment before being provided to the patient. Each health plan uses its own standards, methods, the individual judgment of an employed medical director, or advice from a contracted firm for determining the medical necessity of the services prescribed, which are not transparent or clear to the prescribing clinician or health care provider.
The legislature further finds that there is emerging consensus among health care providers that prior authorization increases administrative burdens and costs. In the 2023 physician workforce report published by the university of Hawaii John A. Burns school of medicine, physicians voted prior authorization as their top concern regarding administrative burden. Furthermore, a physician survey conducted by the American Medical Association reported that ninety-five per cent of physicians attribute prior authorization to somewhat or significantly increased physician burnout, and that more than one-in-three have staff who work exclusively on prior authorization. The survey also found that:
(1) Eighty-three per cent of prior authorization denials were subsequently overturned by health plans;
(2) Ninety-four per cent of respondents said that the prior authorization process always, often, or sometimes delays care;
(3) Nineteen per cent of respondents said prior authorization resulted in a serious adverse event leading to a patient being hospitalized;
(4) Thirteen per cent of respondents said prior authorization resulted in a serious adverse event leading to a life-threatening event or requiring intervention to prevent permanent impairment or damage; and
(5) Seven per cent of respondents said prior authorization resulted in a serious adverse event leading to a patient's disability, permanent body damage, congenital anomaly, birth defect, or death.
The legislature believes that reducing the burdens of prior authorization will assist health care providers, thereby ensuring the health and safety of their patients.
Accordingly, the purpose of this Act is to:
(1) Examine prior authorization practices in the State by requiring utilization review entities to report certain data to the state health planning and development agency; and
(2) Establish the health care appropriateness and necessity commission to make recommendations to improve and expedite the prior authorization process.
SECTION 2. Chapter 323D, Hawaii Revised Statutes, is amended by adding two new sections to part II to be appropriately designated and to read as follows:
"§323D- Prior
authorization; reporting. (a) Each utilization review entity doing business
in the State shall file an annual report containing data related to the prior
authorization of health care services for the preceding calendar year with the
state agency no later than January 1 of each year, in a form and manner
prescribed by the commissioner. The
state agency shall post each report on its website no later than three months before the start of the
reporting period.
(b) The
state agency shall compile the data in each report by provider of health
insurance, health care setting, and line of business, and shall post a report
of findings, including recommendations, on its website no later than March 1 of
the following year after the reporting period.
§323D- Health care appropriateness and necessity
commission; established. (a) There is established the health care
appropriateness and necessity commission within the state agency. The commission shall:
(1) Determine by
research and consensus:
(A) The
most respected peer-reviewed national scientific standards;
(B) Clinical
guidelines; and
(C) Appropriate
use criteria published by federal agencies, academic institutions, and
professional societies,
that correspond to each of
the most frequent clinical treatments, procedures, medications, diagnostic
images, or types of medical equipment prescribed by licensed physicians and other
health care providers in the State that trigger prior authorization
determinations by the utilization review entities;
(2) Assess whether it is appropriate to require prior
authorization for each considered clinical treatment, procedure,
medication, diagnostic image, or type of medical equipment prescribed by
licensed physicians and other health care providers;
(3) Make recommendations on standards for third
party reviewers related to the specialty expertise of those reviewing and for
those discussing a patient's denial with their health care provider; and
(4) Recommend appropriate time frames within which urgent and standard requests
shall be decided.
(b) The members of the commission shall consist
of the following:
(1) Five members representing
insurers and utilization review entities, three of whom shall be appointed by
the governor, one of whom shall be appointed by the president of the senate,
and one of whom shall be appointed by the speaker of the house of
representatives;
(2) Five members
representing physicians, hospitals, and other licensed health care providers, three
of whom shall be appointed by the governor, one of whom shall be appointed by
the president of the senate, and one of whom shall be appointed by the speaker
of the house of representatives; and
(3) Five members
representing consumers of health care, three of whom shall be appointed by the
governor, one of whom shall be appointed by the president of the senate, and one
of whom shall be appointed by the speaker of the house of representatives.
The members of the commission shall
elect a chairperson and vice chairperson from amongst themselves. The director of health, state insurance
commissioner, administrator of the med-QUEST division of the department of
human services, and administrator of the state health planning and development
agency, or their designees, shall be ex-officio, non-voting members.
(c) The commission shall submit a report of its
findings and recommendations regarding information under subsection (a),
including any proposed legislation, to the legislature no later than twenty
days prior to the convening of each regular session.
(d)
The recommendations of the commission shall be advisory
only and not mandatory for health care providers, insurers, and utilization
review entities. The state agency shall
promote the recommendations among health care providers, insurers, and
utilization review entities and shall publish annually in its report to the legislature
the extent and impacts of its use in the State.
(e) The state agency shall seek transparency and agreement among health care providers, insurers, utilization review entities, and consumers related to the most respected clinical, scientific and efficacious standards, guidelines, and appropriate use criteria corresponding to medical treatments and services most commonly triggering prior authorization determinations in order to reduce the current unrest around common prior authorization processes, and also foster automation of prior authorization to the benefit of all. The state agency shall explore means of achieving statewide health sector agreement on means of automating prior authorization determinations in the near future."
SECTION 3. Section 323D-2, Hawaii Revised Statutes, is amended by adding two new definitions to be appropriately inserted and to read as follows:
""Prior authorization" means the process by which a utilization
review entity determines the medical necessity or medical appropriateness of
otherwise covered health care services before rendering the health care
services. "Prior
authorization" includes any health insurer's or utilization review entity's
requirement that an insured or a health care provider notify the insurer or
utilization review entity before providing health care services to determine
eligibility for payment or coverage.
"Utilization review entity" means
an individual or entity that performs prior authorization for one or more of the following entities:
(1) An insurer
governed by chapter 431, article 10A; a mutual benefit society governed by
chapter 432, article 1; a fraternal benefit society governed by chapter 432, article
2; or a health maintenance organization governed by chapter 432D; or
(2) Any other individual that provides, offers to provide, or administers hospital, outpatient, medical, prescription drug, or other health benefits to a person treated by a health care provider in the State under a policy, contract, plan, or agreement."
SECTION 4. New statutory material is underscored.
SECTION 5. This Act shall take effect upon its approval.
INTRODUCED BY: |
_____________________________ |
|
|
Report Title:
Prior Authorization; Utilization Review Entities; Reporting; Health Care Appropriateness and Necessity Commission; State Health Planning and Development Agency
Description:
Requires utilization review entities to submit data relating to the prior authorization of health care services to the State Health Planning and Development Agency. Establishes the Health Care Appropriateness and Necessity Commission within the State Health Planning and Development Agency.
The summary description
of legislation appearing on this page is for informational purposes only and is
not legislation or evidence of legislative intent.